Executive Leadership for a New Era of Biotech Operations & Quality
Martin Lush
Executive Leader | Qualified Person | GxP AI Strategist | QMS Simplification Expert | Non-Executive Director
With over 40 years at the intersection of biotech operations, pharmaceutical quality, and regulatory compliance, I help organizations navigate complexity, modernize their systems, and build real resilience in an unpredictable world.
I’ve led from the shop floor to the boardroom—serving as Global VP in consulting, QA, manufacturing, operations, and supply chain across vaccines, biologics, and sterile injectables. I’m a Qualified Person under permanent provisions and a Non-Executive Director, with deep insight into both execution and oversight.
Today, I challenge outdated thinking and guide forward-looking companies to rewire their quality, compliance, and leadership systems for agility, speed, and impact.
What do I do?
GxP AI Implementation
Practical,
Compliant,
Game-Changing
-
Custom in-house AI education programs to demystify the tech and raise AI literacy across functions
-
Real-world AI applications that improve compliance, reduce cost, and accelerate product release
-
Smarter deviation/CAPA systems with predictive analytics and AI-enabled root cause support
-
Strategies for integrating AI into your quality system—with built-in governance and validation frameworks
Quality Management Systems
From Bureaucracy to Competitive Advantage
-
QMS simplification for speed, flexibility, and leaner operations
-
Quality Maturity Model (QMM) expertise: assess, evolve, and lead
-
Human error prevention strategies grounded in behavioural science
-
Practical redesign of deviation and CAPA processes to prevent recurrence and drive learning
-
Crisis prevention: systems that absorb shock and adapt under pressure
Leadership Development
Built for High-Stakes Environments
-
One-to-one coaching for senior leaders under pressure
-
Embedding risk-based decision making and psychological resilience across teams
-
Culture transformation rooted in accountability, clarity, and future-readiness
Regulatory Compliance
Prepared for What's Next
-
Proactive FDA readiness, including strategy for the new regulatory realities of a Trump 2.0 era
-
Inspection prep that goes beyond checklists—focused on mindset, micro-behaviours, and risk-based thinking
